Expression of vascular endothelial growth factor family messenger RNA in diseased thyroid tissues

Surgery Today

Volumn 32, Issue 9, 2002, Pages 761-768

  Tanaka, Katsuhiro ^a   Kurebayashi, Junichi ^a   Sonoo, Hiroshi ^a   Otsuki, Takemi ^a   Yamamoto, Yutaka ^a   Ohkubo, Sumiko ^a   Yamamoto, Shigeru ^a   Shimozuma, Kojiro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Nodal involvement; Papillary thyroid carcinoma; Vascular endothelial growth factor C

Indexed keywords

MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; FROZEN SECTION; GENE EXPRESSION; GRAVES DISEASE; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; RECURRENT CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID DISEASE; THYROID PAPILLARY CARCINOMA; THYROID SURGERY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARCINOMA, PAPILLARY; ENDOTHELIAL GROWTH FACTORS; FEMALE; GRAVES DISEASE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; THYROID NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036042735     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950200146     Document Type: Article

References (39)

1. The role of vascular permeability factor and basic fibroblast growth factor in tumour angiogenesis
2. The implications of angiogenesis for the biology and therapy of cancer metastasis
3. The biology of vascular endothelial growth factor
4. Angiogenesis
5. Vascular endothelial growth factor is a secreted angiogenic mitogen
6. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid
7. Presence and possible role of vascular endothelial growth factor in thyroid cell growth and function
8. Upregulation of the angiogenic factors PIGF, VEGF and their receptors (Flt-1, Flt-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization
9. Vascular endothelial growth factor gene and protein: Strong expression in thyroiditis and thyroid carcinoma
10. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells
11. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
12. Proteolytic processing regulates receptor specificity and activity of VEGF-C
13. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
14. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
15. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and vascular tumors
16. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
17. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
18. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D
19. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
20. c-fos-induced growth factor/vascular endothelial growth factor Dinduces angiogenesis in vivo and in vitro
21. VEGF-D promotes the metastatic spread of tumor cells via lymphatics
22. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas
23. VEGFc and VEGFR3 expression in human thyroid pathologies
24. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA
25. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
26. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PIGF) associated with malignancy in human thyroid tumors and cell line
27. Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines
28. Stimulation by thyroid-stimulating hormone and Graves' immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo
29. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
30. Expression of vascular endothelial growth factor (VEGF) family members in breast cancer
31. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor C
32. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
33. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
34. Mutant p. 53 potentiates protein kinase C induction of vascular endothelial growth factor expression
35. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells
36. Expression of angiogenesis stimulators and inhibitors in human thyroid tumours and correlation with clinical pathological features
37. Increased angiogenesis in papillary thyroid carcinoma but lack of prognostic importance
38. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis